Compare Quest Diagnostics Inc (DGX) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Toronto-Dominion Bank — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Toronto-Dominion Bank trades at $121.35 (market cap $200.48B). The key difference: Toronto-Dominion Bank is far larger — about 7.6× Quest Diagnostics Inc's market cap, and Toronto-Dominion Bank pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| DGX | TD | |
|---|---|---|
Market Cap | $26.21B | $200.48B |
Sector | Health | Financials |
52-Week High | $238.50 | $124.80 |
52-Week Low | $173.49 | $72.85 |
Enterprise Value | $31.97B | — |
Dividend Yield | 1.45% | 2.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
